Georges El Hachem
Georges El Hachem, MD
Jules Bordet Institute, Brussels, Belgium
I am a Lebanese Medical Oncologist currently working in Breast-Gynecological Oncology and Neuro-Oncology Departments at Erasme University Hospital. I am also engaged in the Clinical Trial Conduct Unit (CTCU) at Jules Bordet Institute in Brussels. I received my Diploma in Internal Medicine and Hematology-Oncology from Saint Georges Hospital University Medical Center- University of Balamand, Beirut in June 2017. This is my second year in Belgium. My first year was at Jules Bordet Institute where I had rotations and oncology consultations in the following fields: Gynecological Malignancies; Breast Cancer; Melanoma; Head and Neck; Sarcoma; Genito-Urinary; Gastro-Intestinal and Thoracic Malignancies. I also attended many academic activities at Jules Bordet Institute, as well as many debates and scientific meetings in Belgium and Europe. I was able to publish many case reports, communications, editorial letters and review articles in peer-reviewed journals view the high level of exposure I had at Jules Bordet Institute. In September 2017, I got the chance to attend for the second time the meeting of the Society of Hematologic Oncology (SOHO) in collaboration with MD Anderson at Houston-Texas, where I had a poster presentation, and I was designed an ambassador for Belgium in the society. Furthermore, I am an active editorial board member in many peer review journals, and a reviewer in the Journal of Clinical Oncology as well as other peer review, open access journals. In addition, I got the Certificate in Medical Oncology of European Society after passing the ESMO exam in September 2017. I am an active member in the Lebanese Society of Medical Oncology (LSMO), Belgian Society of Medical Oncology (BSMO), European Society of Medical Oncology (ESMO), American Society of Clinical Oncology (ASCO) and Society of Hematologic Oncology (SOHO) in affiliation with MD Anderson
Gynecological Malignancies; Breast Cancer; Neuro-Oncology; Supportive care mainly women health/quality of life during/after anti-neoplastic treatments.